Article Details
Retrieved on: 2024-10-23 15:25:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On Wednesday, Rodman & Renshaw adjusted their stance on Alto Neuroscience (NYSE: ANRO), moving from a Buy rating to a Neutral position.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here